Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock

This publication has 47 references indexed in Scilit:

• Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study
  Medicina Intensiva (English Edition), 2012
• Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis
  International Journal of General Medicine, 2012
• Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
  Mediators of Inflammation, 2012
• Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review
  Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2011
• Dynamic lactate indices as predictors of outcome in critically ill patients
  Critical Care, 2011
• High Plasma Level of Long Pentraxin 3 (PTX3) Is Associated with Fatal Disease in Bacteremic Patients: A Prospective Cohort Study
  PLOS ONE, 2011
• Metabolic acidosis in patients with severe sepsis and septic shock: A longitudinal quantitative study
  Critical Care Medicine, 2009
• Procalcitonin increase in early identification of critically ill patients at high risk of mortality*
  Critical Care Medicine, 2006
• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units
  Critical Care Medicine, 1998
• APACHE II
  Critical Care Medicine, 1985